CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 4.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $31,297,271 | +23.0% | 3,931,818 | 0.0% | 37.26% | -5.4% |
| Q3 2023 | $25,438,862 | +4.5% | 3,931,818 | 0.0% | 39.38% | +23.9% |
| Q2 2023 | $24,337,953 | +60.8% | 3,931,818 | 0.0% | 31.78% | +53.4% |
| Q1 2023 | $15,137,499 | +24.2% | 3,931,818 | 0.0% | 20.71% | +26.4% |
| Q4 2022 | $12,188,636 | -22.9% | 3,931,818 | 0.0% | 16.38% | +15.5% |
| Q3 2022 | $15,805,000 | -17.5% | 3,931,818 | 0.0% | 14.18% | -12.3% |
| Q2 2022 | $19,148,000 | -45.7% | 3,931,818 | 0.0% | 16.18% | -21.1% |
| Q1 2022 | $35,268,000 | -20.3% | 3,931,818 | 0.0% | 20.51% | +23.9% |
| Q4 2021 | $44,272,000 | -32.6% | 3,931,818 | 0.0% | 16.56% | -11.9% |
| Q3 2021 | $65,661,000 | -24.8% | 3,931,818 | 0.0% | 18.81% | -14.1% |
| Q2 2021 | $87,326,000 | – | 3,931,818 | – | 21.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
| Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
| OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
| Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
| VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
| Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
| Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
| Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |